EHF-THERAPY AND HIRUDOTHERAPY IN THE COMBINATION TREATMENT OF CHRONIC PELVIC INFLAMMATORY DISEASES IN WOMEN

The aim of the study was to evaluate the effectiveness of the combined use of EHF-puncture and hirudotherapy (HT) in chronic pelvic inflammatory diseases in women and to substantiate the expediency of including a combination of these non-drug therapeutic factors in the combination treatment of pelvic inflammatory diseases (PID). Under observation there were 128 women aged 20 to 45 years (31.8 ± 0.41 years) with chronic adnexitis, chronic endometritis and both diseases at the stage of complete and incomplete remission. In 70.3% of patients, concomitant hormone-dependent diseases were recorded: fibromyoma of the uterine body, endometriosis and their combination. All patients were randomized into 2 groups: the main group (74 subjects) and the comparison group (54 subjects). The multimodality treatment of patients of the main group included EHF-therapy through the action upon biologically active points (BAP) and HT. The effectiveness of the treatment was assessed by the results of the analysis of the visual analogue scale of pain, bimanual and ultrasound examination data in dynamics. The combined use of EHF-puncture and hirudotherapy ensured the achievement of an analgesic effect in 82.9% of cases, an anti-inflammatory effect in 51.8% of cases, a resolving effect in 93.7% of cases, and contributed to the normalization of hemodynamics of the pelvic organs in 68.8% of cases. Under the influence of EHF-puncture and HT, the manifestations of endometriosis and fibromyoma of the uterine body decreased. The results of the study prove the clinical effectiveness of the combined use of EHF-puncture and hirudotherapy in the treatment of PID in women, including those with concomitant hormone-dependent gynecological diseases.